Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Cancer Genetics and Cytogenetics|February 1, 1995
Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort studyS Bonassi, A Abbondandolo, L Camurri, et al.
Mutation Research|May 1, 1988
Chromosome aberrations associated with CAD gene amplification in Chinese hamster cultured cellsL Ottaggio, C Agnese, S Bonatti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1998
Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbonsF Merlo, A Andreassen, A Weston, et al.
Mutation Research|February 3, 2000
5-methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiationP Monti, A Inga, G Scott, et al.
Oncogene|June 29, 2001
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elementsP Campomenosi, P Monti, A Aprile, et al.
Cancer Research|February 11, 1999
N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenicA Inga, F X Chen, P Monti, et al.
Mutation Research|April 18, 2000
The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and factsG Fronza, A Inga, P Monti, et al.
International Journal of Cancer|November 10, 2000
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphomaF Fais, G Fronza, S Roncella, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1996
p53 is frequently mutated in Barrett's metaplasia of the intestinal typeP Campomenosi, M Conio, M Bogliolo, et al.
Experimental Hematology|September 10, 1999
Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipientsM Galotto, G Berisso, L Delfino, et al.
Pageof 11